Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Genmab
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
University of California, Davis
M.D. Anderson Cancer Center
University of Cologne
St. Jude Children's Research Hospital
University Hospital Southampton NHS Foundation Trust
University of Miami
University of Washington
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
International Extranodal Lymphoma Study Group (IELSG)
ADC Therapeutics S.A.
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
University of Nebraska
M.D. Anderson Cancer Center
University of Nebraska
University of Nebraska
University of Nebraska
University of Wisconsin, Madison
M.D. Anderson Cancer Center
University of Cincinnati
University of Birmingham
University of California, Davis
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of Washington
The First Affiliated Hospital with Nanjing Medical University
SCRI Development Innovations, LLC
National Institutes of Health Clinical Center (CC)
Medstar Health Research Institute
Spectrum Pharmaceuticals, Inc
British Columbia Cancer Agency
Universität des Saarlandes
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
Institut Paoli-Calmettes
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
University of Wisconsin, Madison
University of Maryland, Baltimore
University of Miami